Trial Profile
A randomised controlled trial to evaluate the immune response to an adjuvanted 2012 seasonal trivalent inactivated influenza vaccine in adults
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 15 Jan 2020
Price :
$35
*
At a glance
- Drugs Adjuvanted-influenza-virus-vaccine-inactivated-trivalent-Vaxine (Primary) ; ADVAX (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Vaxine
- 14 Jan 2020 Status changed from recruiting to completed.
- 17 Jul 2012 New trial record